BetterLife Pharma Inc.

About BetterLife Pharma Inc.

BetterLife Pharma is an emerging biotechnology company focused on developing and commercializing patient-friendly, non-hallucinogenic compounds to treat neuro-psychiatric and neurological disorders. Their mission is to deliver breakthrough therapeutics for mental health conditions like anxiety, depression, PTSD, and migraines, aiming to build a better life through innovative medicines.

Products & Services

BETR-001 (2-Bromo-LSD):A second-generation LSD derivative molecule that mimics the therapeutic properties of LSD without hallucinogenic side effects. It is a potential therapy for psychiatric disorders like treatment-resistant depression and PTSD, as well as neurological disorders like cluster headaches. It offers advantages over other psychedelics with lower regulatory hurdles and patient self-administration potential.

Specialties

Non-hallucinogenic therapeutics Neuro-psychiatric disorder treatments Neurological disorder treatments Mental health solutions (anxiety, depression, PTSD, migraines)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 1500000 MR: - FA: 1,500,000 FAN: 1500000	D: 2023-03-08 FD: 2023-03-08	-

Private Placement Latest

2023-03-08

$1.5M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Ahmad Doroudian

Chief Executive Officer & Director

H

Hooshmand Sheshbaradaran

Chief Operating Officer

M

Moira Ong

Chief Financial Officer

S

Scott Rudge

Head CMC

A

Abdi Ghaffari

Head Preclinical & Toxicology

A

Adam Halberstadt

Adjunct Professor, Psychiatry

View 10 more team members with Pro

Unlock Full Team Directory

Recent News